ArticleBritish journal of pain2020
Barriers to the wider adoption of medicinal
Article in British journal of pain, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- The role of cannabis-based medicinal products (CBMPs) in managing osteoarthritis symptoms: a scoping review of current evidence and future directions.Clinical rheumatology · 2026Article
- Phytocannabinoids and Male Fertility: Implications ofPlants (Basel, Switzerland) · 2026Review
- Using Cannabis and CBD to Sleep: An Updated Review.Current psychiatry reports · 2024Review
- Real-world patient experience with medicinal cannabis use for symptom management in an Australian advanced cancer setting: a mixed method, cohort study using the theory of planned behaviour framework.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Article
- 'What price do you put on your health?': Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer.Health expectations : an international journal of public participation in health care and health policy · 2023Article
- Expanding Research on Cannabis-Based Medicines for Liver Steatosis: A Low-Risk High-Reward Way Out of the Present Deadlock?Cannabis and cannabinoid research · 2023Article
- Perceptions and Preoccupations of Patients and Physicians Regarding Use of Medical Cannabis as an Intervention Against Chronic Musculoskeletal Pain: Results from a Qualitative Study.Journal of pain research · 2023Article
- Clinical Research Evidence Supporting Administration and Dosing Recommendations of Medicinal Cannabis as Analgesic in Cancer Patients.Journal of clinical medicine · 2022Review
- Medical cannabis, CBD wellness products and public awareness of evolving regulations in the United Kingdom.Journal of cannabis research · 2022Article
- Medical Cannabis: Toward a New Policy and Health Model for an Ancient Medicine.Frontiers in public health · 2022Article
- Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years.Frontiers in pharmacology · 2022Article
- Real World Evidence in Medical Cannabis Research.Therapeutic innovation & regulatory science · 2022Article
- Medicinal cannabis: knowledge, beliefs, and attitudes of Colombian psychiatrists.Journal of cannabis research · 2021Article
- Human Laboratory Models of Cannabis Use: Applications for Clinical and Translational Psychiatry Research.Frontiers in psychiatry · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.